-
Signature
-
/s/ Bruce Blefeld, Attorney-in-Fact
-
Stock symbol
-
ZLAB
-
Transactions as of
-
Apr 1, 2022
-
Transactions value $
-
-$79,787
-
Form type
-
4
-
Date filed
-
11/17/2022, 08:37 PM
Transactions Table
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
transaction |
ZLAB |
American Depositary Shares |
Tax liability |
-$11.2K |
-246 |
-0.98% |
$45.47 |
24.9K |
Apr 1, 2022 |
Direct |
F1, F2 |
transaction |
ZLAB |
American Depositary Shares |
Options Exercise |
$5.56K |
+1.85K |
+7.46% |
$3.00* |
26.7K |
Nov 15, 2022 |
Direct |
F3 |
transaction |
ZLAB |
American Depositary Shares |
Sale |
-$70.2K |
-1.75K |
-6.57% |
$40.00 |
25K |
Nov 15, 2022 |
Direct |
F3 |
transaction |
ZLAB |
American Depositary Shares |
Sale |
-$4K |
-100 |
-0.4% |
$40.03 |
24.9K |
Nov 15, 2022 |
Direct |
F3 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
transaction |
ZLAB |
Stock Options (Right to Buy) |
Options Exercise |
$0 |
-1.85K |
-13.9% |
$0.00 |
11.5K |
Nov 15, 2022 |
American Depositary Shares |
1.85K |
$3.00 |
Direct |
F2 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
Remarks:
President and Head of Global Development for Neuroscience, Autoimmune and Infectious Diseases